<DOC>
	<DOCNO>NCT02380131</DOCNO>
	<brief_summary>Stage I：preoperative therapy - Capecitabine plus oxaliplatin herceptin superior surgery alone patient potentially resectable HER-2 positive gastric cancer liver metastasis ; Stage II : Perioperative therapy - Perioperative Capecitabine plus oxaliplatin herceptin superior adjuvant Capecitabine plus oxaliplatin alone patient potentially resectable HER-2 positive gastric cancer liver metastasis ;</brief_summary>
	<brief_title>Perioperative Chemotherapy With Herceptin For Potentially Resectable HER-2 Positive Gastric Cancer With Liver Metastasis</brief_title>
	<detailed_description>The investigator assess whether addition perioperative regimen XELOX regimen herceptin improve R0 resection rate survival among patient potentially resectable HER-2 positive gastric cancer liver metastasis .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Trastuzumab</mesh_term>
	<criteria>1.Pathological tissue gastric cancer gastric liver biopsy . 2.Immunohistochemistry confirm HER2 ( + ) FISH ( + ) . 3.gastric cancer liver metastasis able resectable lesion . 4.Patients•had receive radiotherapy past organ metastasis peritoneal metastasis . 5.ECOG performance status 01 . 6.Inadequate hematopoietic function： Hemoglobin≥90g/L ; ANC≥1,500/mm3 ; Platelet≥100,000/mm3 7.Inadequate organ function define : Total bilirubin≤1.5 pper limit normal range ( ULN ) ; ALT / AST≤2.5 upper limit normal range ( ULN ) ( ≤5.0 x ULN hepatic metastasis ) ; serum creatinine≤1.5 pper limit normal range ( ULN ) , Serum albumin≥30g/L . 8.expectancy must 3 month . 9.the random blood urine pregnancy test fertile woman must negative result pregnancy test 7 day . 10.Patients male female use reliable contraception contraceptive method end study 30 day later . 11.The operation complete D2 operation ( LNM≥15 ) . 12.LVEF≥50 % 1 . Patients extrahepatic metastasis Include peritoneal metastasis . 3 . Patients malignancy 5 year . 4 . Patients peripheral nerve disease , two hydrogen pyrimidine dehydrogenase ( DPD ) deficiency , upper digestive tract obstruction malabsorption syndrome . 5.Patients hypertension fail control , active bleeding , 3~4 proteinuria , heal wound , romboembolism , heart failure , clinical symptom heart disease . 6.Patients obvious peripheral nervous system disorder , mental disorder disorder central nervous system history . 7.Patients history organ transplantation . 8.Patients medical psychiatric condition disease , investigator 's judgment , would make patient inappropriate entry study . 9.Patients combined antitumor drug outside research program .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>XELOX</keyword>
	<keyword>Herceptin</keyword>
	<keyword>Potentially Resectable Gastric Cancer</keyword>
</DOC>